REMATIB (Upadacitinib) 15mg | Generic JAK1 Inhibitor | Drug International Limited | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

Generic Information: REMATIB (Upadacitinib) — Bangladesh

REMATIB is a generic upadacitinib made by Drug International Limited (DIL), a Bangladeshi manufacturer known for affordable versions of essential medicines. It supplies the selective JAK1 inhibitor as a 15 mg tablet, offered in two pack sizes — 10 tablets for starting out and 30 tablets for a full month. That flexibility makes REMATIB a practical lower-cost alternative to the originator RINVOQ.

What Is REMATIB (Upadacitinib) Used For?

REMATIB is used for immune-mediated inflammatory diseases, as a generic equivalent of RINVOQ:

  • Rheumatoid arthritis — moderate to severe active disease in adults with an inadequate response to TNF inhibitors.
  • Atopic dermatitis — moderate to severe eczema in adults and adolescents 12 years and older.
  • Psoriatic arthritis — active disease in adults with an inadequate response to DMARDs.
  • Ulcerative colitis and Crohn's disease — moderate to severe active disease in adults.

How Does REMATIB (Upadacitinib) Work?

The active drug in REMATIB, upadacitinib, blocks JAK1 — the enzyme that passes inflammatory signals from cytokines into the cell. Quieting JAK1 calms the immune overactivity in the joints, skin and gut that drives these conditions. Because REMATIB is a generic of RINVOQ, its mechanism and effect are identical.

Indications

  • Moderate to severe active rheumatoid arthritis in adults
  • Active psoriatic arthritis in adults
  • Moderate to severe atopic dermatitis in adults and adolescents 12+ years
  • Moderate to severe active ulcerative colitis and Crohn's disease in adults

Dosage & Administration

REMATIB is taken as one 15 mg tablet once daily, with or without food. The 10-tablet pack suits a short starter course, while the 30-tablet pack covers a full month. For bowel disease a higher 45 mg daily induction dose is used before stepping down to 15 mg maintenance. Swallow whole and follow your physician's instructions.

Side Effects

Common side effects are upper respiratory tract infections, nausea, cough and fever. Serious risks include serious infections, shingles, blood clots, major cardiovascular events and certain cancers. A boxed warning covers these, and a tuberculosis test is advised before treatment.

Storage & Handling

Store REMATIB in the original pack at room temperature, protected from moisture and light, and out of reach of children.

Why Choose REMATIB (Generic Upadacitinib)?

  • Two pack sizes — 10 or 30 tablets, so you can start small or buy a full month.
  • Lower-cost generic — the same upadacitinib active ingredient as RINVOQ at a reduced price.
  • DIL manufacturing — Drug International Limited, a Bangladeshi maker with GMP-compliant production.
  • GLT supply chain — GIVE LIFE TIME LIMITED ships batch-traceable REMATIB with documentation worldwide.

How to Order REMATIB (Upadacitinib) from GLT?

  1. Reach GLT on WhatsApp +86 15234153837 or email [email protected] with the pack size and quantity you need.
  2. Receive a formal quotation, payment details and delivery estimate.
  3. Complete payment via our secure channel (Hao Yi Lian / 好易联).
  4. Your order ships with batch records and tracking to delivery.

GLT serves licensed institutions and individual patients; a valid prescription may be requested before dispatch.

FAQ

1. Is REMATIB a generic of upadacitinib?

Yes. REMATIB is a generic upadacitinib made by Drug International Limited in Bangladesh, containing the same active ingredient as RINVOQ.

2. What is the price of REMATIB (generic upadacitinib)?

As a generic it is priced below the originator. Contact GLT for a quotation based on your quantity and destination.

3. What pack sizes does REMATIB come in?

REMATIB is supplied as 15 mg tablets in 10-count and 30-count packs.

4. Where can I buy generic upadacitinib?

You can order REMATIB and other generic upadacitinib brands through GLT via WhatsApp +86 15234153837 or email [email protected].

5. Does REMATIB require a prescription?

Yes, upadacitinib is a prescription medicine, and a valid prescription may be requested before dispatch.

Related Oncology Products

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...